Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Urology Reports
Erschienen in: Current Urology Reports 9/2015

01.09.2015 | Pediatric Urology (M Castellan and R Gosalbez, Section Editors)

Controversies in the Management of Vesicoureteral Reflux

verfasst von: Angela M. Arlen, Christopher S. Cooper

Erschienen in: Current Urology Reports | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Vesicoureteral reflux (VUR) is the abnormal retrograde flow of urine from the bladder into the upper urinary tract. Diagnosis and subsequent management of VUR have become increasingly controversial, with differing opinions over which children should be evaluated for reflux, and when detected, who should undergo treatment. Management goals include prevention of recurrent febrile urinary tract infection (fUTI) and renal injury while minimizing the morbidity of treatment and follow-up. Management options include observation with or without continuous antibiotic prophylaxis and surgical correction via endoscopic, open or laparoscopic/robotic approaches. Management should be individualized and based on patient age, health, risk of subsequent renal injury, clinical course, renal function, and parental preference.
Literatur
1.
Sargent MA. What is the normal prevalence of vesicoureteral reflux? Pediatr Radiol. 2000;30:587–93.PubMedCrossRef
2.
Skoog SJ, Peters CA, Arant Jr BS, et al. Pediatric vesicoureteral reflux guideline panel summary report: clinical practice guidelines for screening siblings of children with vesicoureteral reflux and neonates/infants with prenatal hydronephrosis. J Urol. 2010;184:1145–51.PubMedCrossRef
3.
Shaikh N, Morone NE, Lopez J, et al. Does this child have a urinary tract infection? JAMA. 2007;298:2895–904.PubMedCrossRef
4.
Peters C, Rushton HG. Vesicoureteral reflux associated renal damage: congenital reflux nephropathy and acquired renal scarring. J Urol. 2010;184:265–73.PubMedCrossRef
5.
Nguyen HT, Herndon CD, Cooper C, et al. Nguyen HT, Herndon CD, Cooper C, et al. The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis. J Pediatr Urol 2010;6:212. J Pediatr Urol. 2010;6:212–31.PubMedCrossRef
6.
Knudson MJ, Austin JC, Wald M, et al. Computational model for predicting the chance of early resolution in children with vesicoureteral reflux. J Urol. 2007;178:1824–7.PubMedCrossRef
7.
Peters CA, Skoog SJ, Arant Jr BS, et al. Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol. 2010;184:1134–44.PubMedCrossRef
8.
Knudson MJ, Austin JC, McMillan ZM, et al. Predictive factors of early spontaneous resolution in children with primary vesicoureteral reflux. J Urol. 2007;178:1684–8.PubMedCrossRef
9.
Koyle M, Kirsch A, Barone C, et al. Challenges in childhood urinary tract infection/vesicoureteral reflux investigation and management: calming the storm. Urology. 2012;80:503–8.PubMedCrossRef
10.
Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011;128:595–609.PubMedCrossRef
11.
Juliano TM, Stephany HA, Clayton DB, et al. Incidence of abnormal imaging and recurrent pyelonephritis after first febrile urinary tract infection in children 2 to 24 months old. J Urol. 2013;190:1505–10.PubMedCentralPubMedCrossRef
12.
Nelson CP, Johnson EK, Logvinenko T, et al. Ultrasound as a screening test for genitourinary anomalies in children with UTI. Pediatrics. 2014;133:e394–403.PubMedCentralPubMedCrossRef
13.
Arlen AM, Merriman LS, Kirsch JM, et al. Early Effect of American Academy of Pediatrics UTI Guidelines on Radiographic Imaging and Diagnosis of Vesicoureteral Reflux in the Emergency Room Setting. J Urol 2014. doi: 10.​1016/​j.​juro.​2014.​06.​100.
14.
Wan J, Skoog SJ, Hulbert WC, et al. Executive Committee, Section on Urology, American Academy of Pediatrics. Section on Urology Response to new Guidelines for the diagnosis and management of UTI. Pediatrics. 2012;129:e1051–3.PubMedCrossRef
15.••
The RIVUR Trial Investigators, Hoberman A, Greenfield SP, Mattoo TK, et al. Antimicrobial Prophylaxis for Children with Vesicoureteral Reflux. N Engl J Med. 2014;370:2367–76. Multi-institutional, randomized, placebo-controlled study demonstrating that antibiotic prophylaxis is associated with a substantially reduced risk of recurrent infections in children with vesicoureteral reflux.PubMedCentralCrossRef
16.••
Brandstrom P, Esbjorner E, Herthelius, et al. The Swedish Reflux Trial in Children: III. Urinary tract infection pattern. J Urol. 2010;184:286–91. Multi-institutional, randomized, controlled trial demonstrating a high rate of recurrent febrile urinary tract infections in girls older than one year of age with dilating reflux. Antibiotic prophylaxis and endoscopic injection were associated with decreased infection rate.PubMedCrossRef
17.
Wheeler DM, Vimalachandra D, Hodson EM, et al. Interventions for primary vesicoureteric reflux. Cochrane Database Syst Rev. 2004;3:CD001532.PubMed
18.•
Nguyen HT, Benson CB, Bromley B, et al. Multidisciplinary consensus on the classification of prenatal and postnatal urinary tract dilation (UTD classification system). J Pediatr Urol. 2014;10:982–98. Multidisciplinary panel consensus on postnatal urinary tract dilation with accompanying follow-up algorithm based on the proposed classification system.PubMedCrossRef
19.
Cheng CH, Tsai MH, Huang YC, et al. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy. Pediatrics. 2008;122:1212–7.PubMedCrossRef
20.
21.
Craig JC, Simpson JM, Williams GJ, et al. Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl Med. 2009;361:1748–59.CrossRef
22.
Elder JS, Peters CA, Arant Jr BS, et al. Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children. J Urol. 1997;157:1846–51.PubMedCrossRef
23.•
Alexander SE, Arlen AM, Storm DW, et al. Bladder Volume at Onset of Vesicoureteral Reflux is an Independent Risk Factor for Breakthrough Febrile Urinary Tract Infection. J Urol. 2015;193:1342–6. Retrospective study where bladder volume at VUR onset was normalized for age; children with vesicoureteral reflux at low bladder volumes were found to be at increased risk for breakthrough febrile urinary tract infections.PubMedCrossRef
24.
25.
Cooper CS, Chung BI, Kirsch AJ, et al. The outcome of stopping prophylactic antibiotics in older children with vesicoureteral reflux. J Urol. 2000;163:269–72.PubMedCrossRef
26.
Al-Sayyad AJ, Pike JG, Leonard MP. Can prophylactic antibiotics safely be discontinued in children with vesicoureteral reflux? J Urol. 2005;174:1587–9.PubMedCrossRef
27.
Roussey-Kesler G, Gadjos V, Idres N, et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. J Urol. 2008;179:674–9.PubMedCrossRef
28.
29.
Mak RH, Kuo HJ. Pathogenesis of urinary tract infection: an update. Curr Opin Pediatr. 2006;18:148–52.PubMedCrossRef
30.
Schwab CW, Wu H, Selman H, et al. Spontaneous resolution of vesicoureteral reflux: a 15-year perspective. J Urol. 2002;168:2594–9.PubMedCrossRef
31.
Sjostrom S, Sillen U, Bachelard M, et al. Spontaneous resolution of high grade infantile vesicoureteral reflux. J Urol. 2004;172:694–8.PubMedCrossRef
32.
Lin KY, Chiu NT, Chen MJ, et al. Acute pyelonephritis and sequelae of renal scar in pediatric first febrile urinary tract infection. Pediatr Nephrol. 2003;18:362–5.PubMed
33.
McMillian ZM, Austin JC, Knudson MJ, et al. Bladder volume at onset of reflux on initial cystogram predicts spontaneous resolution. J Urol. 2006;176:1838–41.CrossRef
34.
O’Donnell B, Puri P. Treatment of vesicoureteral reflux by endoscopic injection of Teflon. Br Med J. 1984;289:7–9.CrossRef
35.
Kirsch AJ, Perez-Brayfield M, Scherz HC. The modified STING procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol. 2004;171:2413–6.PubMedCrossRef
36.
Lackgren G, Kirsch AJ. Endoscopic treatment of vesicoureteral reflux. BJUI. 2010;105:1332–47.CrossRef
37.
Lendvay TS, Sorensen M, Cowan CA, et al. The evolution of vesicoureteral reflux management in the era of dextranomer/hyaluronic acid copolymer: a pediatric health information system database review. J Urol. 2006;176:1864–7.PubMedCrossRef
38.
39.
Kaye JD, Srinivasan AK, Delaney C, et al. Clinical and radiographic results of endoscopic injection for vesicoureteral reflux: Defining measures of success. J Pediatr Urol. 2012;8:297–303.PubMedCrossRef
40.
Kalisvaart JF, Scherz HC, Cuda S, et al. Intermediate to long-term follow-up indicates low risk of recurrence after Double HIT endoscopic treatment for primary vesicoureteral reflux. J Pediatr Urol. 2012;8:359–65.PubMedCrossRef
41.
42.
Routh JC, Inman BA, Reinberg Y. Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: Systemic Review. Pediatrics. 2010;125:1010–9.PubMedCrossRef
43.
Elder JS, Diaz M, Calamone AA, et al. Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol. 2006;175:716–22.PubMedCrossRef
44.
Arlen AM, Pakalniskis BL, Cooper CS. Asymptomatic chronic partial obstruction of a normal ureter following dextranomer/hyaluronic acid copolymer (Deflux®) injection for grade I vesicoureteral reflux. J Pediatr Urol. 2012;8:e27–30.PubMedCrossRef
45.
Ehrlich RM, Gershman A, Fuchs G. Laparoscopic vesicoureteroplasty in children; initial case reports. Urol. 1994;433:255–61.CrossRef
46.
Janetschek G, Radmayr C, Bartsch G. Laparoscopic ureteral anti-reflux plasty reimplantation; first clinical experience. Ann Urol. 1995;29:101–5.
47.
Atala A, Kavoussi LR, Goldstein DS, et al. Laparoscopic correction of vesicoureteral reflux. J Urol. 1993;150:748–51.PubMed
48.
Peters CA, Woo R. Intravesical robotically assisted bilateral ureteral reimplantation. J Endourol. 2005;19:618–22.PubMedCrossRef
49.
Casale P, Patel RP, Kolon TF. Nerve sparing robotic extravesical ureteral reimplantation. J Urol. 2008;179:1987–90.PubMedCrossRef
50.
Gundeti MS, Kojima Y, Haga N, et al. Robotic-assisted laparoscopic reconstructive surgery in the lower urinary tract. Curr Urol Rep. 2013;14:333–41.PubMedCrossRef
51.
Marchini GS, Hong YK, Minnillo BJ, et al. Robotic assisted laparoscopic ureteral reimplantation in children: case matched comparative study with open surgical approach. J Urol. 2011;185:1870–5.PubMedCrossRef
52.
Smith RP, Oliver JL, Peters CA. Pediatric robotic extravesical ureteral reimplantation: comparison with open surgery. J Urol. 2011;185:1876–81.PubMedCrossRef
53.
Stanasel I, Atala A, Hemal A. Robotic assisted ureteral reimplantation: current status. Curr Urol Rep. 2013;14:32–6.PubMedCrossRef
54.
Akhavan A, Avery D, Lendvay TS. Robot-assisted extravesical ureteral reimplantation: outcomes and conclusions from 78 ureters. J Pediatr Urol. 2014;10:864–8.PubMedCrossRef
55.
56.
Dangle PP, Shah A, Gundeti MS. Robot-assisted laparoscopic ureteric reimplantation: extravesical technique. BJU Int. 2014;114:630–2.PubMedCrossRef
57.
Cooper CS, Austin JC. Vesicoureteral reflux: who benefits from surgery? Urol Clin N Am. 2004;31:535–41.CrossRef
58.
Jodal U, Smellie JM, Lax H, et al. Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatr Nephrol. 2006;21:785–92.PubMedCrossRef
Metadaten
Titel
Controversies in the Management of Vesicoureteral Reflux
verfasst von
Angela M. Arlen
Christopher S. Cooper
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Current Urology Reports / Ausgabe 9/2015
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-015-0538-2

Weitere Artikel der Ausgabe 9/2015

Current Urology Reports 9/2015 Zur Ausgabe

Benign Prostatic Hyperplasia (K McVary, Section Editor)

Estrogens and Male Lower Urinary Tract Dysfunction

Office Urology (N Shore, Section Editor)

Use of Advanced Practice Providers as Part of the Urologic Healthcare Team

Prostate Cancer (A Kibel, Section Editor)

Screening for Prostate Cancer—Beyond Total PSA, Utilization of Novel Biomarkers

Genetics and Microenvironment (X Cathelineau, Section Editor)

Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors?

Benign Prostatic Hyperplasia (K McVary, Section Editor)

Nocturia: Current Evaluation and Treatment for Urology

Benign Prostatic Hyperplasia (K McVary, Section Editor)

Tolterodine in the Treatment of Male LUTS

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Stufenschema weist Prostatakarzinom zuverlässig nach

22.04.2024 Prostatakarzinom Nachrichten

Erst PSA-Test, dann Kallikrein-Score, schließlich MRT und Biopsie – ein vierstufiges Screening-Schema kann die Zahl der unnötigen Prostatabiopsien erheblich reduzieren: Die Hälfte der Männer, die in einer finnischen Studie eine Biopsie benötigten, hatte einen hochgradigen Tumor.

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

20.04.2024 EAU 2024 Kongressbericht

Beim chronischen Harnwegsinfekt bei Frauen wird bisher meist eine Antibiotikaprophylaxe eingesetzt. Angesichts der zunehmenden Antibiotikaresistenz erweist sich das Antiseptikum Methenamin-Hippurat als vielversprechende Alternative, so die Auswertung einer randomisierten kontrollierten Studie.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise